Botanix up on study results

29/01/2018 - 15:20

Bookmark

Save articles for future reference.

Shares in medical dermatology company Botanix Pharmaceuticals, led by Perth-based chairman Graham Griffiths and executive director Matt Callahan, have jumped more than 20 per cent today after the company announced successful results from an acne patient study.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options